Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the systemic exposure to B17MP (active metabolite of BDP) as AUC0-t, after four single inhalations of fixed combination CHF1535 100/6 NEXT DPI® (total dose: BDP 400 μg / FF 24 μg) in comparison with a free combination of BDP DPI and formoterol DPI licensed products in asthmatic adult and adolescent population.
Critère d'inclusion
- Asthma (patients aged 12-65 years)